Holen Sie sich die Stockscreener-App
19.94
2.84%
0.55
Handel nachbörslich:
19.82
-0.12
-0.60%
Schlusskurs vom Vortag:
$19.39
Offen:
$19.3
24-Stunden-Volumen:
3.47M
Relative Volume:
0.95
Marktkapitalisierung:
$3.65B
Einnahmen:
$637.78M
Nettoeinkommen (Verlust:
$239.40M
KGV:
16.74
EPS:
1.1909
Netto-Cashflow:
$307.21M
1W Leistung:
+5.11%
1M Leistung:
-17.81%
6M Leistung:
-60.45%
1J Leistung:
-61.10%
1-Tages-Spanne:
$19.27
$20.00
1-Wochen-Bereich:
$18.36
$20.14
52-Wochen-Spanne:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
19.94 | 3.55B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Herabstufung | Truist | Buy → Hold |
| 2026-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Doximity AI Push Reshapes Healthcare Tech On Russell 1000 - Kalkine Media
Doximity, Inc. (DOCS) Stock Report: Analyst Ratings Point To A Promising 26% Upside - DirectorsTalk Interviews
Can Russell 1000 Pressure Weigh on Doximity Shares? - Kalkine Media
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - Yahoo Finance
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - The Motley Fool
Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN
Doximity’s SWOT analysis: stock faces pressure from AI spending, slowing growth - Investing.com
Doximity shares hit record low as soft guidance and AI margin pressures spark 25% plunge - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Doximity, Inc. (DOCS) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Doximity forecasts fiscal 2027 revenue of $664M-$676M amid 'AI investment year' and softer pharma ad visibility - MSN
Handelsbanken Fonder AB Sells 315,900 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity to Present at the William Blair 46th Annual Growth Stock Conference - 01net
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
5 Revealing Analyst Questions From Doximity’s Q1 Earnings Call - Yahoo Finance
AI Reliance Poses Growing Operational, Regulatory, and Reputational Risks for Doximity - TipRanks
Doximity Leadership Shift And AI Push Reframe Growth And Valuation Outlook - Yahoo Finance
Stock market today: S&P 500, Dow, Nasdaq futures gain as Trump clears NVDA's H200 sales to China—Cisco Systems, Doximity in focus (updated) - MSN
DOCS Stock Price, Quote & Chart | DOXIMITY INC-CLASS A (NYSE:DOCS) - ChartMill
Is It Time To Reassess Doximity (DOCS) After Its Sharp Share Price Slide? - simplywall.st
1,246 Doximity (DOCS) shares withheld to cover RSU taxes for interim PFO - Stock Titan
Doximity (NYSE: DOCS) CEO granted PSUs while shares withheld for tax - Stock Titan
Doximity (DOCS) outlines physician network, Clinical AI Suite and main business risks - Stock Titan
Why Are Doximity (DOCS) Shares Soaring Today - Yahoo Finance
J.P. Morgan Upgrades Doximity(DOCS.US) to Hold Rating, Cuts Target Price to $28 - Moomoo
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Doximity (DOCS) Q1 CY2026 Deep Dive: AI Investments Accelerate Amid Macro and Policy Headwinds - Yahoo Finance
Why Doximity (DOCS) Shares Are Sliding Today - Yahoo Finance
Northwestern Mutual Wealth Management Co. Purchases 1,298,492 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Is Down 27.0% After Softer 2027 Outlook And Higher AI SpendWhat's Changed - Sahm
Doximity Stock Hits Day Low of $17.16 Amid Price Pressure - Markets Mojo
Another Wall Street analyst slashes Doximity stock price outlook - thestreet.com
Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN
Doximity shares plunge 20% on soft guidance and AI margin pressures - MSN
Doximity, Inc. 2026 Q4ResultsEarnings Call Presentation (NYSE:DOCS) 2026-05-16 - Seeking Alpha
Assessing Doximity (DOCS) Valuation After A Steep Share Price Decline - Yahoo Finance
Doximity (DOCS) Margin Compression Challenges Bullish AI Growth Narratives After FY 2026 Results - Sahm
Barclays Downgrades Doximity (NYSE:DOCS) to Hold - MarketBeat
Raymond James Upgrades Doximity (DOCS) - MSN
Why Is Doximity Stock Trending Right Now - Kalkine Media
RBC Capital Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $28 - Moomoo
Doximity Earnings Call: Cash‑Rich, Slower Growth, Big AI Bet - The Globe and Mail
Doximity Analyst Ratings and Price Targets | NYSE:DOCS - Benzinga
Doximity Inc (DOCS) Stock Price, Quote, News & History - Benzinga
Doximity (DOCS) founders report combined stakes equal to 77% voting power - Stock Titan
Doximity, Inc. Stock 12‑Month Price Target Cut to $24.92, Implies 38% Upside - TradingView
Leerink Partners Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Doximity (NYSE:DOCS) Trading 8.6% HigherStill a Buy? - MarketBeat
Doximity Earnings: Strong AI Signals, But Monetization Still Pending (NYSE:DOCS) - Seeking Alpha
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care - Zacks Investment Research
BTIG downgrades Doximity (DOCS) - MSN
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.90%
4.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):